2019
Awarded the Korean Patent Grand Prize
Obtained the approval for sales of Class II in vitro diagnostics from the Chinese FDA (沈阳阿一生物科技有限公司)
Signed a contract with Yongchenghanyuan (永成汉源), a China/Hong Kong-based large asset management company, with regards to investments and Nasdaq listings
Signed a contract with Samsung Securities Co., Ltd., as a lead underwriter
he signing of Patron partnership agreement as well as 'CUBEBIO-UICC Cancer Early Detection and Self-Diagnosis' program agreement with the Union for International Cancer Control (UICC)
Awarded the 2019 Moneytoday Grand Prize for Innovative Technology in the field of innovative technology 'Cancer Self-Diagnostic Device'
Signed a contract for the export of cancer self-diagnostic devices in the Russian Federation and CIS countries.
Awarded the Global Top Technology Grand Prize at the 2019 Moneytoday World Class Small-Mighty Enterprise Award
Participation in the UICC-led World Cancer Leaders' Summit in Kazakhstan by invitation only